285 related articles for article (PubMed ID: 29694290)
1. The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home.
Prudencio J; Cutler T; Roberts S; Marin S; Wilson M
J Manag Care Spec Pharm; 2018 May; 24(5):423-429. PubMed ID: 29694290
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
[TBL] [Abstract][Full Text] [Related]
4. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
[TBL] [Abstract][Full Text] [Related]
5. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
Sherrill CH; Pentecost A; Wood EE
J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
[TBL] [Abstract][Full Text] [Related]
7. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
Korcegez EI; Sancar M; Demirkan K
J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population.
Maxwell LG; McFarland MS; Baker JW; Cassidy RF
Pharmacotherapy; 2016 Mar; 36(3):348-56. PubMed ID: 26877253
[TBL] [Abstract][Full Text] [Related]
9. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes.
Sherrill CH; Houpt CT; Dixon EM; Richter SJ
J Manag Care Spec Pharm; 2020 May; 26(5):600-609. PubMed ID: 32347180
[TBL] [Abstract][Full Text] [Related]
10. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
Chung N; Rascati K; Lopez D; Jokerst J; Garza A
J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
[TBL] [Abstract][Full Text] [Related]
11. A sustainable business model for comprehensive medication management in a patient-centered medical home.
Fabel PH; Wagner T; Ziegler B; Fleming PA; Davis RE
J Am Pharm Assoc (2003); 2019; 59(2):285-290. PubMed ID: 30611660
[TBL] [Abstract][Full Text] [Related]
12. Development of a Pharmacoeconomic Model to Demonstrate the Effect of Clinical Pharmacist Involvement in Diabetes Management.
Ourth H; Nelson J; Spoutz P; Morreale AP
J Manag Care Spec Pharm; 2018 May; 24(5):449-457. PubMed ID: 29694293
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
14. Pharmacist-Managed Diabetes Center Interventions Ensure Quality and Safety in Elderly Patients.
Twigg G; Motsko J; Thomas J; David T
Consult Pharm; 2017 May; 32(5):299-310. PubMed ID: 28483010
[TBL] [Abstract][Full Text] [Related]
15. Pharmacists providing care in statewide physician organizations: findings from the Michigan Pharmacists Transforming Care and Quality Collaborative.
Coe AB; Choe HM; Diez HL; Rockey NG; Ashjian EJ; Dorsch MP; Kim HM; Farris KB
J Manag Care Spec Pharm; 2020 Dec; 26(12):1558-1566. PubMed ID: 33251995
[No Abstract] [Full Text] [Related]
16. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
[TBL] [Abstract][Full Text] [Related]
17. Effect of a Virtual Pharmacy Review Program: A Population Health Case Study.
Muraywid B; Butkievich LE; Myers B
J Manag Care Spec Pharm; 2020 Jan; 26(1):24-29. PubMed ID: 31880223
[TBL] [Abstract][Full Text] [Related]
18. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
Morello CM; Nguyen T; Tao L; Hirsch JD
Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
[No Abstract] [Full Text] [Related]
19. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
Padiyara RS; D'Souza JJ; Rihani RS
J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
[TBL] [Abstract][Full Text] [Related]
20. Patient-centered medical home pharmacists' impact on composite quality care measures for patients with uncontrolled type 2 diabetes.
Schwenka N; Donovan A; Franck L; Coan C; McAdam-Marx C; Shin E
J Am Pharm Assoc (2003); 2023; 63(5):1545-1552.e4. PubMed ID: 37301508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
